Wells et al developed a score for the myelodysplastic syndrome (MDS) based on flow cytometric findings. One component involves the presence of various abnormalities involving myeloid cells. The authors are from the Hematologics, Inc, Fred Hutchinson Cancer Research Center, and the University of Washington, Seattle.

To read more or access our algorithms and calculators, please log in or register.